Caminar Reduce Los AVE en Hombre

Embed Size (px)

Citation preview

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    1/9

    Barbara J. Jefferis, Peter H. Whincup, Olia Papacosta and S. Goya WannametheeProtective Effect of Time Spent Walking on Risk of Stroke in Older Men

    Print ISSN: 0039-2499. Online ISSN: 1524-4628Copyright 2013 American Heart Association, Inc. All rights reserved.

    is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231Strokepublished online November 14, 2013;Stroke.

    http://stroke.ahajournals.org/content/early/2013/11/14/STROKEAHA.113.002246

    World Wide Web at:The online version of this article, along with updated information and services, is located on the

    http://stroke.ahajournals.org/content/early/2013/11/14/STROKEAHA.113.002246http://stroke.ahajournals.org/content/suppl/2013/11/14/STROKEAHA.113.002246.DC1.htmlhttp://stroke.ahajournals.org/content/early/2013/11/14/STROKEAHA.113.002246
  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    2/9

    Background and PurposeOlder adults have the highest risks of stroke and the lowest physical activity levels. It is

    important to quantify how walking (the predominant form of physical activity in older age) is associated with stroke.

    MethodsA total of 4252 men from a UK population-based cohort reported usual physical activity (regular walking,

    cycling, recreational activity, and sport) in 1998 to 2000. Nurses took fasting blood samples and made anthropometricmeasurements.

    ResultsAmong 3435 ambulatory men free from cardiovascular disease and heart failure in 1998 to 2000, 195 first strokes

    occurred during 11-year follow-up. Men walked a median of 7 (interquartile range, 312) hours/wk; walking more

    hours was associated with lower heart rate, D-dimer, and higher forced expiratory volume in 1 second. Compared with

    men walking 0 to 3 hours/wk, men walking 4 to 7, 8 to 14, 15 to 21, and >22 hours had age- and region-adjusted hazard

    ratios (95% confidence intervals) for stroke of 0.89 (0.601.31), 0.63 (0.401.00), 0.68 (0.351.32), and 0.36 (0.14

    0.91), respectively, P(trend)=0.006. Hazard ratios were somewhat attenuated by adjustment for established and novel

    risk markers (inflammatory and hemostatic markers and cardiac function [N-terminal pro-brain natriuretic peptide]) and

    walking pace, but linear trends remained. There was little evidence for a doseresponse relationship between walkingpace and stroke; comparing average pace or faster to a baseline of slow pace, the hazard ratio for stroke was 0.65 (95%

    confidence interval, 0.440.97), which was fully mediated by time spent walking.

    ConclusionsTime spent walking was associated with reduced risk of onset of stroke in doseresponse fashion, independent

    of walking pace. Walking could form an important part of stroke-prevention strategies in older people. (Stroke.

    2014;45:00-00.)

    Key Words: aged cohort analysis motor activity pace stroke walking

    Protective Effect of Time Spent Walkingon Risk of Stroke in Older Men

    Barbara J. Jefferis, PhD; Peter H. Whincup, PhD; Olia Papacosta, MSc; S. Goya Wannamethee, PhD

    Original Article

    http://stroke.ahajournals.org/content/suppl/2013/11/14/STROKEAHA.113.002246.DC1.html
  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    3/9

    2 Stroke January 2014

    towns in 1978 to 1980 (age, 4059 years). Men were followed upfor stroke morbidity and all-cause mortality. In 1998 to 2000, 4252participants (age, 6079 years) attended for follow-up measurements

    (77% response rate).

    17

    A total of 811 with pre-existing myocardialinfarction, stroke, or heart failure and 6 confined to a wheelchair wereexcluded to reduce potential for reverse causality, leaving 3435 men.

    Clinical Data, Ethical ApprovalMen completed questionnaires and nurses measured height, weight,blood pressure (BP), and forced expiratory volume in 1 second(FEV

    1)17and recorded an ECG12 (including resting heart rate), and

    Minnesota coding criteria were used to define atrial fibrillation (8.3.1and 8.3.3) and definite and possible left ventricular hypertrophy (3.1

    and 3.3). Fasting venous blood samples were collected and analyzedfor total and high-density lipoprotein-cholesterol, triglycerides,18andvitamin C.19CRP was assayed by ultrasensitive nephelometry (DadeBehring). Plasma levels of D-dimer were measured with ELISA(Biopool AB), as was von Willebrand factor antigen (DAKO). NT-proBNP was measured using the Elecsys 2010 electrochemilumines-cence method (Roche Diagnostics, Burgess Hill, United Kingdom).13All relevant local research ethics committees provided ethical approv-al and all men provided informed written consent to the investigation.

    Assessment of PAIn 1998 to 2000, men self-reported usual pattern of PA under theheadings of regular daily walking or cycling, recreational activity,and sporting (vigorous) activity. Men reported usual walking duringan average week (1) duration: number of hours spent on all forms ofwalking, (2) distance: number of miles walked in total; (3) pace: slow,steady average, fairly brisk, and fast (4 mph). Men reporting recre-ational and sporting activity were classified according to whether theyparticipated in vigorous activities at least once a month. Recreationalactivity included, for example, gardening, pleasure walking (hiking),and do-it-yourself jobs. Sporting activity included, for example, run-

    ning golf swimming and tennis A PA score (validated in relation

    or end of follow-up period, whichever occurred first. Date of entryinto the study in 1998 to 2000 was used as the time origin. The propor-tional hazards assumption was examined using time varying covari-

    ates, calculating interactions of predictor variables and a function ofsurvival time and including them in the models. Examination of timevarying covariates indicated that proportionality assumptions were notviolated. The hazard ratios (HRs) for categories of walking in 1998to 2000 were estimated and the overall association was tested withthe continuous association among walking (1) time, (2) distance, (3)pace, and stroke risk, adjusted for sex, age (continuous variable), andregion of residence. Time and duration of walking were adjusted forpace, and pace adjusted for time. Models were also adjusted for par-ticipation in vigorous recreational or sporting activities. Models werenext adjusted for covariates associated with both stroke and walking;

    established risk factors (alcohol and tobacco use, social class [basedon occupational group manual {skilled manual, unskilled, or partlyskilled}, or nonmanual {professional, managerial, technical, skillednonmanual occupations}]), and then biological risk factors (as con-tinuous variables): first body mass index and then systolic BP, totaland high-density lipoprotein-cholesterol and triglycerides, next FEV

    1

    was added, finally, novel risk markers, CRP, D-dimer, and NT-proBNPwere added. Interactions were tested using likelihood ratio tests.Analyses were repeated excluding the first 2 years of follow-up.

    ResultsAnalyses are based on 3357 ambulatory men (mean age, 68.3

    years) who were free from CHD, stroke, and heart failure at

    entry. Men walked a median of 7 hours per week (interquar-

    tile range, 312 hours). The correlation between categories

    of hours walked and walking pace was r=0.08 (P

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    4/9

    Jefferis et al Walking and Stroke in Seniors 3

    Table 1. Characteristics of Men According to Time Spent Walking per Week (N=2995 Men)

    03 h/wk (n=803) 47 h/wk (n=921) 814 h/wk (n=785) 1521 h/wk (n=270) 22 h/wk (n=216) P(Trend)*

    Age, y 68.21 68.56 68.53 67.99 66.63 0.005Social class, % (n) 15 U/wk 13.6 (107) 17.0 (153) 19.8 (150) 16.2 (43) 16.5 (35)

    Tobacco, % (n) 0.411

    Current smoker 13.0 (104) 11.6 (107) 13.4 (105) 13.4 (36) 17.1 (37)

    Physical activity score

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    5/9

    4 Stroke January 2014

    to a similar degree when adjusted separately (not presented) or

    together (model 5), and the linear trend remained significant.

    We did not observe evidence for an interaction between time

    spent walking and pace (likelihood ratio test, P=0.1). In sen-

    sitivity analyses excluding the first 2 years of follow-up time,

    the point estimates were similar with slightly wider CIs, butsignificant trends remained.

    The risk of stroke was reduced for average pace compared

    with slow pace HR 0.66 (0.430.99) with no further reduction

    for fairly brisk HR 0.64 (0.391.07), so the average and fairly

    brisk were combined and compared with slow pace. The HR for

    stroke was significantly reduced in average or brisk pace com-

    pared with slow pace, 0.62 (0.420.92) for model 2 (Table 5) but

    was fully mediated on adjustment for either walking distance

    (HR 0 67 [0 44 1 02]) or duration (HR 0 67 [0 43 1 04])

    PA and stroke, and a strong inverse doseresponse association

    between time spent walking and risk of stroke, independent

    of walking pace, vigorous physical activity, established, and

    novel risk factors. Results suggest that the total volume of

    walking rather than the intensity is important for stroke pre-

    vention. We investigated a range of plausible mechanisms toexplain associations between walking and stroke, including

    lipids, hypertension, markers of inflammation, and endothe-

    lial dysfunction, but none fully mediated the associations with

    time spent walking.

    Comparison With Other StudiesFindings about total PA and risk of stroke are mixed; inverse,

    u-shape, and even positive associations are reported.2 We

    f d k id f i i ti b t t t l

    Table 2. Association Between Total Physical Activity and Onset of Stroke, up to June 2010

    Total Leisure Time

    Physical Activity None Occasional Light Moderate

    Moderately Vigorous

    and Vigorous Total P(Trend)

    Participants (n) 269 690 569 475 992 2995

    Person-years 2279 6451 5570 4768 9938 29 001

    Stroke events rates/1000 (n) 7.9 (18) 8.1 (52) 7.5 (42) 5.7 (27) 5.6 (56) 6.7 (195)

    HR (95% CI)*

    Model 1 1.0 1.08 (0.631.85) 0.99 (0.571.71) 0.81 (0.441.48) 0.79 (0.461.34) 0.092

    Model 2 1.0 1.05 (0.611.82) 0.93 (0.531.63) 0.80 (0.431.47) 0.77 (0.451.34) 0.100

    Model 1=age+region; model 2=model 1+alcohol intake (none/occasional, 115 U/wk, >15 U/wk)+vigorous recreational or sporting activity+smoking history

    (never-smoker, ex-smoker, and current smoker)+social class (nonmanual, manual, and armed forces)+total cholesterol+HDL-C+loge

    (triglycerides)+SBP+taking

    blood pressurelowering medication+BMI+atrial fibrillation+left ventricular hypertrophy. BMI indicates body mass index; CI, confidence interval; HDL-C, high-density

    lipoprotein-cholesterol; HR, hazard ratio; and SBP, systolic blood pressure.

    *From Cox regression models of physical activity level and all stroke.

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    6/9

    Jefferis et al Walking and Stroke in Seniors 5

    was associated with stroke fits with other data; this consis-

    tency strengthens our speculation that it is a true biological

    finding, although we acknowledge that it could be because of

    issues with measurement of other types of PA. We did not find

    consistent evidence that walking pace was related to stroke

    onset; time spent walking explained the raised risk in slow-

    paced walkers, nor did we find that distance walked protected

    against stroke, although distance may be harder to recall accu-

    rately than usual pace or time spent walking A large volume

    atherosclerosis and clot rupture that also act in CHD, whereas

    effects on hemorrhagic stroke may act through BP-related

    mechanisms, but we could not test this hypothesis.

    Strengths and Limitations

    This study benefits from prospective data with high follow-up

    rates, multiple measures of walking habit (pace, time spent

    walking, and distance), and other types of self-reported habitual

    PA bi d i b th PA 16 20 d ti t lk

    Table 4. Association Between Time Spent Walking per Week and Onset of Stroke, up to June 2010

    Time Spent

    Walking/Wk 03 h 47 h 814 h 1521 h 22 h Total P(Trend)

    Participants (n) 633 747 612 210 183 2385

    Person-years 6024 7341 6024 2095 1060 23 196

    Stroke events

    rate/1000 (n)

    8.0 (48) 7.7 (56) 5.5 (33) 5.3 (11) 2.7 (5) 6.6 (153)

    HR (95% CI)*

    Model 1 1.0 0.89 (0.601.31) 0.63 (0.401.00) 0.68 (0.351.32) 0.36 (0.140.91) 0.006

    Model 2 1.0 0.88 (0.601.31) 0.65 (0.411.02) 0.69 (0.351.34) 0.34 (0.130.87) 0.006

    Model 3 1.0 0.90 (0.611.33) 0.66 (0.421.04) 0.70 (0.361.36) 0.35 (0.140.88) 0.008

    Model 4 1.0 0.89 (0.601.33) 0.66 (0.421.04) 0.70 (0.361.36) 0.35 (0.140.88) 0.007

    Model 5 1.0 0.91 (0.611.34) 0.66 (0.421.04) 0.70 (0.361.36) 0.35 (0.140.89) 0.008

    Model 1=age+region; model 2=model 1+alcohol intake (none/occasional, 115 U/wk, >15 U/wk)+vigorous recreational or sporting activity+smoking history

    (never-smoker, ex-smoker, and current smoker)+social class (nonmanual, manual, and armed forces)+total cholesterol+HDL-C+loge(triglycerides)+SBP+taking blood

    pressurelowering medication+BMI+atrial fibrillation+left ventricular hypertrophy; model 3=model 2+walking pace; model 4=model 3+FEV1; and model 5=model

    3+loge(C-reactive protein)+log

    e(D-dimer)+log

    e(NT-proBNP). BMI indicates body mass index; CI, confidence interval; FEV

    1, forced expiratory volume in 1 second; HDL-C,

    high-density lipoprotein-cholesterol; HR, hazard ratio; NT-proBNP, N-terminal pro-brain natriuretic peptide; and SBP, systolic blood pressure.

    *From Cox regression models of physical activity level and all stroke.

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    7/9

    6 Stroke January 2014

    are required for identifying activity types. Although we cannot

    entirely exclude residual confounding as an explanation for our

    findings, we adjusted for a wide range of important behavioral

    and social confounders including other dimensions of walk-ing and other types of physical activities. To reduce the risk of

    reverse causality, we excluded men with pre-existing physician

    diagnosed cardiovascular disease or confined to a wheelchair,

    as these men have increased mortality risks and are likely limit

    their PA because of their health. We also excluded the first 2

    years of follow-up in sensitivity analyses. Unlike other studies

    of walking pace and duration, we could investigate the mediat-

    ing role of novel and established biological risk factors, which

    may be on the causal pathway between walking and stroke risk.We were able to distinguish between subtypes of stroke in a

    subset of cases, and, as reported elsewhere,12ischemic strokes

    were more common than hemorrhagic strokes (a small minor-

    ity) in older adults. In a sensitivity analysis of men with com-

    puted tomographyconfirmed ischemic stroke, findings were

    similar to those for all participants. Our study examines only

    men, and we cannot generalize results to older women; how-

    ever, the sample is socioeconomically representative of older

    men in the United Kingdom and has exceptionally high follow-

    up rates. One meta-analysis found borderline evidence for sex

    differences,22and another reported that more vigorous PA may

    be required for protection against stroke in women than in men,2

    but this may be because population levels of PA are lower in

    women than in men.

    In conclusion, time spent walking was associated with risk

    of stroke in a doseresponse fashion independent of walk-

    ing pace and moderate to vigorous PA, indicating that among

    ld d il lki ld b fi i ll d i k f

    from the American Heart Association/American Stroke Association Stroke

    Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease

    Interdisciplinary Working Group; Cardiovascular Nursing Council;

    Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism

    Council; and the Quality of Care and Outcomes Research InterdisciplinaryWorking Group: the American Academy of Neurology affirms the value of

    this guideline. Stroke. 2006;37:15831633.

    2. Diep L, Kwagyan J, Kurantsin-Mills J, Weir R, Jayam-Trouth

    A. Association of physical activity level and stroke outcomes in

    men and women: a meta-analysis. J Womens Health (Larchmt).

    2010;19:18151822.

    3. Huerta JM, Chirlaque MD, Tormo MJ, Gavrila D, Arriola L, Moreno-

    Iribas C, et al. Physical activity and risk of cerebrovascular disease in

    the European Prospective Investigation into Cancer and Nutrition-Spain

    study. Stroke. 2013;44:111118.

    4. Abbott RD, Rodriguez BL, Burchfiel CM, Curb JD. Physical activity inolder middle-aged men and reduced risk of stroke: the Honolulu Heart

    Program.Am J Epidemiol. 1994;139:881893.

    5. DiPietro L. Physical activity in aging: changes in patterns and their rela-

    tionship to health and function.J Gerontol A Biol Sci Med Sci. 2001;56

    Spec No 2:1322.

    6. Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of

    prospective cohort studies.Br J Sports Med. 2008;42:238243.

    7. Sattelmair JR, Kurth T, Buring JE, Lee IM. Physical activity and risk of

    stroke in women. Stroke. 2010;41:12431250.

    8. Noda H, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S,

    et al; JACC Study Group. Walking and sports participation and mor-

    tality from coronary heart disease and stroke. J Am Coll Cardiol.

    2005;46:17611767.

    9. Hu FB, Stampfer MJ, Colditz GA, Ascherio A, Rexrode KM, Willett

    WC, et al. Physical activity and risk of stroke in women. JAMA.

    2000;283:29612967.

    10. Longstreth WT Jr, Bernick C, Fitzpatrick A, Cushman M, Knepper L,

    Lima J, et al. Frequency and predictors of stroke death in 5,888 partici-

    pants in the Cardiovascular Health Study.Neurology. 2001;56:368375.

    11. McGinn AP, Kaplan RC, Verghese J, Rosenbaum DM, Psaty BM, Baird

    AE, et al. Walking speed and risk of incident ischemic stroke among

    postmenopausal women. Stroke. 2008;39:12331239.

    12 Wannamethee SG Whincup PH Lennon L RumleyA Lowe GD Fibrin

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    8/9

  • 7/25/2019 Caminar Reduce Los AVE en Hombre

    9/9

    * P(trend) tested with linear regression for continuous variables and chi squared for categorical variablesadjusted for inter-observer variationadjusted for time of daygeometric mean||adjusted for inter-observer variation and height squared.

    BMI (kg/m2) 27.96 26.90 25.97 26.82 3349